| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CohBar, Inc. | Chief Scientific Officer | Common Stock | 10K | $11.2K | $1.12 | Aug 11, 2021 | Direct |
| CohBar, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 750K | Aug 11, 2021 | Direct | ||
| Anebulo Pharmaceuticals, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 72.6K | Feb 29, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. | Feb 29, 2024 | 1 | $0 | 4/A | Mar 8, 2024 | Chief Scientific Officer |
| ANEB | Anebulo Pharmaceuticals, Inc. | Feb 29, 2024 | 1 | $0 | 4 | Mar 1, 2024 | Chief Scientific Officer |
| ANEB | Anebulo Pharmaceuticals, Inc. | Dec 9, 2022 | 1 | $0 | 4 | Dec 13, 2022 | Chief Scientific Officer |
| ANEB | Anebulo Pharmaceuticals, Inc. | Jun 1, 2022 | 1 | $0 | 4 | Jun 7, 2022 | Chief Scientific Officer |
| ANEB | Anebulo Pharmaceuticals, Inc. | May 20, 2022 | 0 | $0 | 3 | May 24, 2022 | Chief Scientific Officer |
| CWBR | CohBar, Inc. | Aug 11, 2021 | 3 | -$12.8K | 4 | Aug 13, 2021 | Chief Scientific Officer |